Navigation Links
Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD

PISGAH FOREST, N.C., Dec. 7, 2012 /PRNewswire/ --  Pisgah Laboratories, Inc., an innovative intellectual property and drug development company located in Western North Carolina, was recently recognized for their technical achievements to reduce the Nation's drug abuse crisis. The Center for Lawful Access and Abuse Deterrence (CLAAD) sponsored the Top 5 Technologies Award contest to provide companies an opportunity to showcase their approach to drug abuse deterrence. The findings by the independent panel of contest judges placed Pisgah's technology platform into the selected Top 5.

The contest's sponsor, CLAAD, is a national non-profit coalition focused on the prevention of the misuse, abuse and diversion of prescription pharmaceutical products. As its name suggests, the organization simultaneously advocates legitimate patient access to such medications. The contest was established to increase public awareness and support the pharmaceutical industry's effort to scientifically address the immense drug abuse problem.  The public announcement of Pisgah's standing in the contest was announced at CLAAD's November 27th, 2012 National Prescription Drug Abuse Prevention Strategy meeting in Washington, D.C.

Numerous patent allowances and product development updates have been reported over the past year that describe Pisgah's first flagship product, an abuse deterrent form of hydrocodone. Now, the technical recognition by CLAAD is a notable crown to Pisgah's achievements, but the company is also rapidly developing their marketing and branding strategy. In order to brand and support their technology platform, Pisgah has launched P2P INTERVENTIONS™, Ultimately, the technology website may serve as a resource and provide access by the public, and the medical community, to patent information on the abuse deterrent features available through Pisgah's innovations.

Clearly, this integrated approach of technical accomplishment to meet market needs and addressing the multitude of related business issues in advance of a launch has made Pisgah attractive to potential marketing partners. According to Todd Stamps, who is responsible for promoting Pisgah's drug abuse deterrence business, "Pisgah is uniquely positioned to help fill empty product pipelines with a host of pain management products which are patent protected and offer performance enhancing benefits." He knowingly added, "What other market opportunity could combine both exceptional growth with a sustaining financial model?" 

Besides filling empty pipelines, Pisgah's technology is quite applicable to extending existing brand life-cycles. Many well-known branded products have come under fierce generic competition which is rapidly eroding the brands' revenues. The brands' market value through name recognition may remain quite high during the sales decline, but the endpoint is obvious. Existing branded products may be enticed to offer an abuse-deterrent line extension to revitalize their brand and create a rising sales tide. As examples, a return to top-line growth could well be applicable to branded products such as Vicodin®, Oxycontin®, and other pain management drugs. In addition, the often abused AD(H)D drugs, Adderall® and Ritalin® could use a revamping to increase sales while providing an additional abuse deterrent benefit.

In the meantime, Pisgah continues to develop their platform on combined business, marketing and technical fronts to provide a solid foundation to selected branding and marketing partners. Currently, Pisgah is prosecuting a number of product brand names through the FDA and USPTO trademarking process in order to be ready for launch implementation. For those interested in joining Pisgah's program as a brand or marketing partner, please contact Mr. Stamps through the number below.


Todd Stamps


This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Pisgah Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
2. Unique Conference Tackles Opioid Abuse Epidemic
3. New Federal Legislation Can Help Combat Teen Cough Medicine Abuse
4. The Partnership at Announces New Partners in National Medicine Abuse Action Campaign
5. Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women
6. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
7. Verizon to Detail Health Care Fraud, Waste & Abuse - The Next Generation at National Association for Medicaid Program Integrity 2012 Conference, Sept. 18
8. Georgia Prescription Drug Abuse Prevention Initiative Launches Awareness Campaign
9. U.S. Senate Resolution Urges Communities, Parents to Fight Teen Medicine Abuse
10. New Lockton Report Analyzes Prescription Drug Abuse and Its Effect on Workers Compensation
11. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 --> ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... has found that immunotherapy can be efficiently combined with ...
(Date:11/26/2015)... -- 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ... transplantation is expected to boost the market growth, as 3D ... --> 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied ... the need to integrate dose form selection in early phase drug development. The ... organization supporting and bringing together the UK’s emerging life sciences companies, corporate partners, ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of ... Empowerment ™ attracts volunteers together who want to combine talents and resources to ... stakeholders in the process. The non-profit launched its first major fundraiser on November ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... factory direct sauna parts and accessories. , Sauna accessories help improve the bather ... style and personality. From basic styles for the purist looking for simplicity in ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
Breaking Medicine News(10 mins):